tyrosine and bay 11-7082

tyrosine has been researched along with bay 11-7082 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bencze, G; Cohen, P; Krishnan, N; Tonks, NK	1
Cai, L; Cong, W; Jin, L; Niu, C; Ruan, D; Tan, Y; Tao, Y; Wang, Y; Xuan, Y; Zhan, K	1

Other Studies

2 other study(ies) available for tyrosine and bay 11-7082

Article	Year
The anti-inflammatory compound BAY-11-7082 is a potent inhibitor of protein tyrosine phosphatases. The FEBS journal, 2013, Volume: 280, Issue:12 Topics: Animals; Anti-Inflammatory Agents; Catalytic Domain; Cell Line; Enzyme Inhibitors; Humans; Kinetics; Lipopolysaccharides; Macrophages; Mice; Models, Molecular; Nitriles; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Sulfones; Surface Properties; Tyrosine; Vanadates	2013
Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-κB signaling activation in the heart. Journal of molecular and cellular cardiology, 2015, Volume: 89, Issue:Pt B Topics: Animals; Apoptosis; Cardiotonic Agents; Catalase; Cell Line; Diabetes Mellitus, Experimental; Inflammation; Mice, Transgenic; Myocardium; NF-kappa B; Nitriles; Nitrosation; Organ Specificity; Reactive Nitrogen Species; Reactive Oxygen Species; Signal Transduction; Sulfones; Tyrosine	2015

Article

Year

The anti-inflammatory compound BAY-11-7082 is a potent inhibitor of protein tyrosine phosphatases.

The FEBS journal, 2013, Volume: 280, Issue:12

Topics: Animals; Anti-Inflammatory Agents; Catalytic Domain; Cell Line; Enzyme Inhibitors; Humans; Kinetics; Lipopolysaccharides; Macrophages; Mice; Models, Molecular; Nitriles; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Sulfones; Surface Properties; Tyrosine; Vanadates

2013

Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-κB signaling activation in the heart.

Journal of molecular and cellular cardiology, 2015, Volume: 89, Issue:Pt B

Topics: Animals; Apoptosis; Cardiotonic Agents; Catalase; Cell Line; Diabetes Mellitus, Experimental; Inflammation; Mice, Transgenic; Myocardium; NF-kappa B; Nitriles; Nitrosation; Organ Specificity; Reactive Nitrogen Species; Reactive Oxygen Species; Signal Transduction; Sulfones; Tyrosine

2015